DAFTAR PUSTAKA
1. Ahmet Gokce, Fatih Rüştü Yalcinkaya, Mürsel Davarci, Mevlana Derya Balbay. 2010.
The Relationship Between Serum Lipid Level and Benign Prostat Hyperplasia. The
New Journal of Medicine, 148-150.
2. Ajit Vikram and Poduri Ramarao. 2010. Lipids in the pathogenesis of Benign Prostate
Hyperplasia: emerging connections.
3. Alberto Briganti, Umberto Capitanio, Nazareno Suardi, Andrea Gallina, Andrea
Salonia, Marco Bianchi, Manuela Tutolo, Valerio Di Girolamo, Giorgio Guazzoni,
Patrizio Rigatti, Francesco Montorsi. 2009. Benign Prostat Hyperplasia and its
Aetiologies. European Urology Supplements 8, 865–871
4. Barkin Jack. 2010. Benign prostatic hyperplasia: Prostate problems are among the
number one reasons, why men over 50 visit their physicians.
5. Firas Abdollah, Alberto Briganti, Nazareno Suardi, Fabio Castiglione, Andrea Gallina,
Umberto Capitanio, Francesco Montorsi. 2011. Metabolic Syndrome and Benign
Prostatic Hyperplasia: Evidence of a Potential Relationship, Hypothesized Etiology,
and Prevention. Korean Journal of Urology.
6. Herbert Lepor. 2004. Pathofisiologi, Epidemiology and Natural History of Benign
Prostat Hyperplasia. Treatment of LUTS and BPH, Department of Urology, New York
University School of Medicine.
7. James B. Meigs, Beth Mohr, Michael J. Barry, Mary McNaughton Collins, John B.
McKinlay. 2001. Risk factors for clinical BPH in a community-based population of
healthy aging men. Journal of Clinical Epidemiology. 935–944.
8. J. de la Rosette, G. Alivizatos, S. Madersbacher, C. Rioja Sanz, J. Nordling, M.
Emberton, S. Gravas, M.C. Michel, M. Oelke,. 2006. Guidelines on Benign Prostat
Hyperplasia. European Association of Urology. 10-17.
9. J. Kellogg Parsons, H. Ballentine Carter, Alan W. Partin, B. Gwen Windham, E. Jeffrey
Metter, Luigi Ferrucci, Patricia Landis, and Elizabeth A. Platz. 2006. Metabolic Factors
Associated with Benign Prostatic Hyperplasia. The Journal of Clinical Endocrinology
& Metabolism 91(7):2562–2568
10. J. Kellogg Parsons, Jaclyn Bergstrom, and Elizabeth Barrett-Connor. 2008. Lipids,
Lipoproteins, and Risk of Benign Prostatic Hyperplasia in Community Dwelling Men.
BJU International, February 101 (3).13-318
11. J. Kellogg Parsons. 2011. Lifestyle factors, benign prostatic hyperplasia, and lower
urinary tract symptoms. Current Opinion in Urology, 21:1–4.
12. Jeannette M. Potts. 2004. Essential Urology, A Guide To Clinical Practice. 191-202.
13. National Cholesterol Education Program. 2011. Lipid Profile Reference Range. Lipid
Risk Categories Revised May.
14. Patrick. C. Walsh. Alan B. Reti, E. Darracott Vaughan Jr. 2011. Campbells Urology
Eighth Edition. 2559-2561, 2571-2592.
15. Reshu Tewari, Singh Rajender, Shankar M. Natu1, Divakar Dalela, Apul Goel, Madhu
M. Goel, Pushpa Tandon. 2012. Diet, obesity and prostate health: Are we missing the
link?. Journal of Andrology.
16. Sadao Suzuki, Elizabeth A Platz, Ichiro Kawachi, Walter C Willett, and Edward
Giovannucci. 2012. Intakes of energy and macronutrients and the risk of benign
prostatic hyperplasia. The American Journal of Clinical Nutrition.
17. Sastroasmoro Sudigdo. 2011. Dasar Dasar Metodologi Penelitian Klinis Edisi 4.
18. Sjamsuhidajat R, de Jong W. 2005. Buku Ajar Ilmu Bedah. Edisi 2. Jakarta: Penerbit
Buku Kedokteran EGC. 570-579.
19. Steven Haffner and Heinrich Taegtmeyer. 2003. Epidemic obesity and metabolic
syndrome: Circulation. 1541-1545.
20. The American Urological Association, 2011. I-PSS Symptom Index.
21. Thomas Dayspring. Understanding the entire lipid profile.
22. Yat-Ching Tong. 2009. Male Lower Urinary Tract Symptoms/ Benign Prostatic
Hyperplasia and Metabolic Syndrome. Incont Pelvic Floor Dysfunct; 3(2):49-51
